DRD2 and schizophrenia: The dopamine hypothesis of schizophrenia theorizes that hyperactivity of dopamine 2 receptor (D2R) neurotransmission in subcortical and limbic regions of the brain may contribute to positive symptoms of schizophrenia, potentially in part due to an increase in D2R density [41,42,43,44,45].